Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1992 1
1994 1
1995 1
1997 1
1999 1
2000 1
2001 2
2002 4
2003 1
2004 2
2005 7
2006 10
2007 3
2008 11
2009 6
2010 6
2011 6
2012 3
2013 3
2014 1
2019 1
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 21300679

66 results
Results by year
Filters applied: . Clear all
Page 1
An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine.
Langley JM, Predy G, Guasparini R, Law B, Diaz-Mitoma F, Whitstitt P, Tapiero B, Dionne M, Tomovici A, Mills E, Halperin SA. Langley JM, et al. Vaccine. 2007 Jan 22;25(6):1121-5. doi: 10.1016/j.vaccine.2006.09.053. Epub 2006 Oct 2. Vaccine. 2007. PMID: 17045366 Clinical Trial.
Epidemiology of pertussis and Haemophilus influenzae type b disease in Canada with exclusive use of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b pediatric combination vaccine and an adolescent-adult tetanus-diphtheria-acellular pertussis vaccine: implications for disease prevention in the United States.
Greenberg DP, Doemland M, Bettinger JA, Scheifele DW, Halperin SA; IMPACT Investigators, Waters V, Kandola K. Greenberg DP, et al. Pediatr Infect Dis J. 2009 Jun;28(6):521-8. doi: 10.1097/INF.0b013e318199d2fc. Pediatr Infect Dis J. 2009. PMID: 19436236
66 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page